44 min listen
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
ratings:
Length:
23 minutes
Released:
Mar 8, 2023
Format:
Podcast episode
Description
In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:Barriers to screening HDV screening based on patient risk factors Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)Reflex testing Availability of commercial testingMonitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNALimitations to evaluating advanced fibrosis in patients with HDVData on novel HDV therapies (eg, bulevirtide and lonafarnib)Extending HDV therapy (eg, peginterferon) based on treatment responseStopping rules (eg, HDV RNA negativity, HBsAg loss) for discontinuing HDV therapyFaculty:Maria Buti, MDProfessor of MedicineHospital Universitario Vall d’HebronBarcelona, SpainRichard H. Davis, PA-CSenior PAGastroenterologyUniversity of FloridaUF HealthGainesville, FloridaLink to full program: http://bit.ly/3yp1Lxf
Released:
Mar 8, 2023
Format:
Podcast episode
Titles in the series (100)
EASL 2020 Virtual Conference: Rapid Audio Recap: Hear insights from hepatology expert, Stefan Zeuzem, MD, on some of the most important new viral hepatitis data reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver. The studies highlighted in this podcast focus on HCV elimination and the treatment of HCV, HBV, and HDV infection. by CCO Infectious Disease Podcast